Category icon
Endpoints in Heart Failure Drug Development

Aliza Hussain, Arunima Misra, Biykem Bozkurt,

Category icon
USC Discussion: Percutaneous Mechanical Circulatory Support

Rani Upadhyay, Alexander G Truesdell, Mir Babar Basir

Category icon
Percutaneous Mechanical Circulatory Support

Rani Upadhyay, Hussayn Alrayes, Scott Arno, et al

Category icon
Cardiogenic Shock: Protocols, Teams, Centers, and Networks

Alex F Warren, Carolyn Rosner, Raghav Gattani, et al

Category icon
Cardiac Transplant and Ventricular Assist in Heart Failure

Michael T Cain, Michael S Firstenberg, Joseph C Cleveland Jr,

Category icon
Describing and Classifying Shock: Recent Insights

Ashleigh Long, Amin Yehya, Kelly Stelling, et al

Category icon
Baroreflex Activation Therapy for the Treatment of HFrEF

Faiez Zannad, Jörn Schmitt , Ainhoa Robles Mezcua et al

Category icon
Tips and Tricks in Imaging Your Patients With Valvular Heart Disease

Philippe Pibarot, Patrizio Lancellotti, Jose Luis Zamorano et al

Category icon
CardioMEMS Implantation Using Gadolinium-based Contrast Agent

Aniket S Rali, Lynne W Stevenson, Sandip K Zalawadiya,

Category icon
Tips and Tricks in Imaging Your Patients With Valvular Heart Disease

Philippe Pibarot, Patrizio Lancellotti, Jose Luis Zamorano et al

Category icon
Baroreflex Activation Therapy for the Treatment of HFrEF

Faiez Zannad, Jörn Schmitt , Ainhoa Robles Mezcua et al

Category icon
Value of Telemonitoring and Telemedicine in Heart Failure Management

Gian Franco Gensini, Camilla Alderighi, Raffaele Rasoini, et al

Category icon
Asia Pacific Online Symposium on Cardiac Rhythm Management

Shu Zhang, Seow Swee Chong, David O’Donnell et al

Category icon
LVAD as Destination Therapy

Jorge Silva Enciso, Eric Adler, Barry H Greenberg,

Category icon
CCM® Around the World

Thomas M Helms, Karl-Heinz Kuck, William T Abraham et al

Category icon
Describing and Classifying Shock: Recent Insights

Ashleigh Long, Amin Yehya, Kelly Stelling, et al

Category icon
Temporary Mechanical Circulatory Support in Acute Heart Failure

Federica Jiritano, Valeria Lo Coco, Matteo Matteucci, et al

About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Related Articles

Articles

Endpoints in Heart Failure Drug Development

Aliza Hussain, Arunima Misra, Biykem Bozkurt,

Published:

Citation: Cardiac Failure Review 2022;8:e01.

Percutaneous Mechanical Circulatory Support

Rani Upadhyay, Hussayn Alrayes, Scott Arno,

Published:

Citation: US Cardiology Review 2021;15:e21.

Cardiogenic Shock: Protocols, Teams, Centers, and Networks

Alex F Warren, Carolyn Rosner, Raghav Gattani,

Published:

Citation: US Cardiology Review 2021;15:e18.

Cardiac Transplant and Ventricular Assist in Heart Failure

Michael T Cain, Michael S Firstenberg, Joseph C Cleveland Jr,

Published:

Citation: US Cardiology Review 2021;15:e16.